Does BLESELUMAB Cause Focal segmental glomerulosclerosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Focal segmental glomerulosclerosis have been filed in association with BLESELUMAB. This represents 10.9% of all adverse event reports for BLESELUMAB.
6
Reports of Focal segmental glomerulosclerosis with BLESELUMAB
10.9%
of all BLESELUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From BLESELUMAB?
Of the 6 reports, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLESELUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BLESELUMAB Cause?
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)